INNsight Newsletter - November Edition

INNsight Newsletter - November Edition

Welcome to the INNsight Newsletter, where we share with you the latest news and insights from IQVIA Global Market Insights. This month's thought leadership includes:

  • An Update on Treatment Options and Pipeline Developments for Type 1 and 2 Diabetes
  • From Mexico to Chile: Understanding the Opportunity and Challenges in Latin America’s Pharmaceutical Markets
  • Delving Deeper into the Immunology and Respiratory Markets
  • IQVIA’s 3Q23 Pharmaceutical Market Outlook Webinar


An Update on Treatment Options and Pipeline Developments for Type 1 and 2 Diabetes

Diabetes is a long-term chronic metabolic disease characterized by hyperglycemia, which imposes a global annual economic burden of USD 966 billion in associated healthcare costs. This article will provide an update on current treatment options for type 1 and 2 diabetes and outline the latest development activities of key experimental drugs with data sourced from IQVIA Pipeline Link, a proprietary drug pipeline database. Read more


From Mexico to Chile: Understanding the Opportunities and Challenges in Latin America’s Pharmaceutical Markets

Despite ongoing political and economic challenges, the outlook for global pharmaceutical sales is improving, with aggregate growth (in US dollars at constant exchange rates) forecast to accelerate to 9.2% in 2023, from 7.8% in 2022. Global pharmaceutical sales are forecast to post a compound annual growth rate (CAGR) of 7.8% over 2022–2027, compared to 6.6% over 2017–2022. Read more


Delving deeper into the immunology and respiratory markets

This article explores some of the indications and products which dominate and drive growth within the immunology and respiratory diseases areas.??Psoriasis is a key driver of the immunology market due to its many successful new therapies.??Immunology is another high-value, fast-growing therapy area, with a global 2021-22 year-on-year (YOY) growth rate of 13%. Read more


WEBINAR WATCH: Launch Excellence VIII: Building excellent launches in the post pandemic environment?(On-Demand)

Watch on demand this webinar, which analyses the most recent IQVIA data on innovative prescription medicine launches in 8 key markets: the US, Germany, France, Italy, Spain, UK, China, and Japan, identifying how post-Pandemic environmental and economic challenges combine with longer term launch trends to impact the ability of many launches to reach their true commercial potential, and how companies can plan and prepare to launch excellently in the future.?Watch it here


To learn about our solutions and how we can support your business, follow this link.



要查看或添加评论,请登录

社区洞察